Article metrics

Download PDFPDF

725 Phase I safety and preliminary efficacy of PM8002 in subjects with advanced solid tumors, a bispecific antibody targeting PD-L1 and VEGF-A
Free

 

Online download statistics by month:

Online download statistics by month: November 2022 to January 2024

AbstractFullPdf
Nov 2022542033
Dec 2022124018
Jan 202396019
Feb 2023154023
Mar 2023220045
Apr 2023126013
May 2023240031
Jun 2023162015
Jul 2023134015
Aug 2023112013
Sep 202356014
Oct 2023132010
Nov 2023522031
Dec 2023126027
Jan 2024108015
Total28540322